COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic

Christopher M. Tessier; Alexander Kokkinos; Geltrude Mingrone; Chrysi Koliaki; Juleen R. Zierath; Christos S. Mantzoros

doi:10.1016/j.metabol.2021.154769

King's College London

King's main site

Research portal

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic

Research output: Contribution to journal › Editorial › peer-review

Christopher M. Tessier, Alexander Kokkinos, Geltrude Mingrone, Chrysi Koliaki, Juleen R. Zierath, Christos S. Mantzoros

Original language	English
Article number	154769
Journal	Metabolism: clinical and experimental
Volume	119
DOIs	https://doi.org/10.1016/j.metabol.2021.154769
Published	Jun 2021
Additional links	Link to publication in Scopus

Bibliographical note

Funding Information: C.S.M. reports grants, personal fees, and other from AltrixBio, Coherus Biosciences, and Novo Nordisk, personal fees and non-financial support from Ansh, Aegerion, California Walnut Commission, and personal fees from Amgen, Lumos, GENFIT, Intercept, Regeneron, CardioMetabolic Health Conference and The Metabolic Institute of America. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

Geltrude Mingrone (Diabetes)

View graph of relations

King's College London - Homepage

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic

Bibliographical note

King's Authors

By the same authors

With some of the same researchers

From the same journal